157 related articles for article (PubMed ID: 33851620)
21. Malignant mesothelioma in situ: morphologic features and clinical outcome.
Churg A; Galateau-Salle F; Roden AC; Attanoos R; von der Thusen JH; Tsao MS; Chang N; De Perrot M; Dacic S
Mod Pathol; 2020 Feb; 33(2):297-302. PubMed ID: 31375770
[TBL] [Abstract][Full Text] [Related]
22. Well-differentiated papillary mesothelioma, possibly giving rise to diffuse malignant mesothelioma: a case report.
Washimi K; Yokose T; Amitani Y; Nakamura M; Osanai S; Noda H; Kawachi K; Takasaki H; Akaike M; Kameda Y
Pathol Int; 2013 Apr; 63(4):220-5. PubMed ID: 23692423
[TBL] [Abstract][Full Text] [Related]
23. A Case of Solitary Well-Differentiated Papillary Mesothelioma with Invasive Foci in the Pleura.
Shimizu S; Yoon HE; Ito N; Tsuji T; Funakoshi Y; Utsumi T; Sakaguchi M; Tsujimura T; Kasai T; Hiroshima K; Matsumura A
Pathol Int; 2017 Jan; 67(1):45-49. PubMed ID: 27886416
[TBL] [Abstract][Full Text] [Related]
24. Utility of Methylthioadenosine Phosphorylase Compared With BAP1 Immunohistochemistry, and CDKN2A and NF2 Fluorescence In Situ Hybridization in Separating Reactive Mesothelial Proliferations From Epithelioid Malignant Mesotheliomas.
Berg KB; Dacic S; Miller C; Cheung S; Churg A
Arch Pathol Lab Med; 2018 Dec; 142(12):1549-1553. PubMed ID: 30059257
[TBL] [Abstract][Full Text] [Related]
25. Well-differentiated papillary mesothelioma of the peritoneum: a borderline mesothelioma. Report of two cases and review of literature.
Bürrig KF; Pfitzer P; Hort W
Virchows Arch A Pathol Anat Histopathol; 1990; 417(5):443-7. PubMed ID: 2122588
[TBL] [Abstract][Full Text] [Related]
26. A unique case of well differentiated papillary mesothelioma involving an inguinal hernia.
Anirudhan TN; Chakravarthy R; Jothishankar P
Indian J Pathol Microbiol; 2012; 55(4):546-8. PubMed ID: 23455802
[TBL] [Abstract][Full Text] [Related]
27. Aberrant Pax-8 expression in well-differentiated papillary mesothelioma and malignant mesothelioma of the peritoneum: a clinicopathologic study.
Xing D; Banet N; Sharma R; Vang R; Ronnett BM; Illei PB
Hum Pathol; 2018 Feb; 72():160-166. PubMed ID: 29241740
[TBL] [Abstract][Full Text] [Related]
28. Well-differentiated papillary mesothelioma with invasive foci.
Churg A; Allen T; Borczuk AC; Cagle PT; Galateau-Sallé F; Hwang H; Murer B; Murty VV; Ordonez N; Tazelaar HD; Wick M
Am J Surg Pathol; 2014 Jul; 38(7):990-8. PubMed ID: 24618613
[TBL] [Abstract][Full Text] [Related]
29. BAP1 immunohistochemistry has limited prognostic utility as a complement of CDKN2A (p16) fluorescence in situ hybridization in malignant pleural mesothelioma.
McGregor SM; McElherne J; Minor A; Keller-Ramey J; Dunning R; Husain AN; Vigneswaran W; Fitzpatrick C; Krausz T
Hum Pathol; 2017 Feb; 60():86-94. PubMed ID: 27771374
[TBL] [Abstract][Full Text] [Related]
30. Peritoneal malignant mesothelioma (PMM), and primary peritoneal serous carcinoma (PPSC) and reactive mesothelial hyperplasia (RMH) of the peritoneum. Immunohistochemical and fluorescence in situ hybridisation (FISH) analyses.
Kawai T; Tominaga S; Hiroi S; Ogata S; Nakanishi K; Kawahara K; Sonobe H; Hiroshima K
J Clin Pathol; 2016 Aug; 69(8):706-12. PubMed ID: 26729015
[TBL] [Abstract][Full Text] [Related]
31. Fine-needle aspiration of a well-differentiated papillary mesothelioma in the inguinal hernia sac: A case report and review of literature.
Wheeler YY; Burroughs F; Li QK
Diagn Cytopathol; 2009 Oct; 37(10):748-54. PubMed ID: 19373910
[TBL] [Abstract][Full Text] [Related]
32. The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma.
Singhi AD; Krasinskas AM; Choudry HA; Bartlett DL; Pingpank JF; Zeh HJ; Luvison A; Fuhrer K; Bahary N; Seethala RR; Dacic S
Mod Pathol; 2016 Jan; 29(1):14-24. PubMed ID: 26493618
[TBL] [Abstract][Full Text] [Related]
33. p16/CDKN2A FISH in Differentiation of Diffuse Malignant Peritoneal Mesothelioma From Mesothelial Hyperplasia and Epithelial Ovarian Cancer.
Ito T; Hamasaki M; Matsumoto S; Hiroshima K; Tsujimura T; Kawai T; Shimao Y; Marutsuka K; Moriguchi S; Maruyama R; Miyamoto S; Nabeshima K
Am J Clin Pathol; 2015 Jun; 143(6):830-8. PubMed ID: 25972325
[TBL] [Abstract][Full Text] [Related]
34. Diffuse mesothelioma of the peritoneum: a pathological study of 64 tumours treated with cytoreductive therapy.
Lee M; Alexander HR; Burke A
Pathology; 2013 Aug; 45(5):464-73. PubMed ID: 23846294
[TBL] [Abstract][Full Text] [Related]
35. Cytologic Differential Diagnosis of Malignant Mesothelioma and Reactive Mesothelial Cells With FISH Analysis of p16.
Hiroshima K; Wu D; Hasegawa M; Koh E; Sekine Y; Ozaki D; Yusa T; Walts AE; Marchevsky AM; Nabeshima K; Tada Y; Shimada H; Tagawa M
Diagn Cytopathol; 2016 Jul; 44(7):591-8. PubMed ID: 27079839
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic strategies for well-differentiated papillary mesothelioma of the peritoneum.
Lee YK; Jun HJ; Nahm JH; Lim TS; Park JS; Ahn JB; Rha SY; Chung HC; Oh HE; Song JS; Yang WI; Kim HS
Jpn J Clin Oncol; 2013 Oct; 43(10):996-1003. PubMed ID: 23964112
[TBL] [Abstract][Full Text] [Related]
37. Peritoneal papillary mesothelioma in situ: BAP1 mutation with indolent behavior for 15 years.
Vitlarov N; Burtscher E; Pfeiffenberger E; Wahl A; Hodja V; Jasarevic Z; Kashofer K; Offner FA
Virchows Arch; 2023 Dec; 483(6):873-878. PubMed ID: 37428268
[TBL] [Abstract][Full Text] [Related]
38. Usefulness of p16/CDKN2A fluorescence in situ hybridization and BAP1 immunohistochemistry for the diagnosis of biphasic mesothelioma.
Wu D; Hiroshima K; Yusa T; Ozaki D; Koh E; Sekine Y; Matsumoto S; Nabeshima K; Sato A; Tsujimura T; Yamakawa H; Tada Y; Shimada H; Tagawa M
Ann Diagn Pathol; 2017 Feb; 26():31-37. PubMed ID: 28038708
[TBL] [Abstract][Full Text] [Related]
39. Well-differentiated papillary mesothelioma: a clinicopathological and immunohistochemical study of 18 cases with additional observation.
Chen X; Sheng W; Wang J
Histopathology; 2013 Apr; 62(5):805-13. PubMed ID: 23530588
[TBL] [Abstract][Full Text] [Related]
40. Sarcomatoid Mesothelioma: A CDKN2A molecular analysis of 53 cases with immunohistochemical correlation with BAP1.
Zaleski M; Kalhor N; Fujimoto J; Wistuba I; Moran CA
Pathol Res Pract; 2020 Dec; 216(12):153267. PubMed ID: 33176261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
